Global Masiroxavir Tablets Market Growth 2026-2032
The global Masiroxavir Tablets market size is predicted to grow from US$ 110 million in 2025 to US$ 854 million in 2032; it is expected to grow at a CAGR of 37.3% from 2026 to 2032.
Baloxavir Marboxil Tablets is a new, oral, single-dose anti-influenza virus drug belonging to cap-dependent endonuclease inhibitors. It exerts its effect by inhibiting influenza virus gene replication, which can rapidly eliminate the virus, shorten the course of disease, and reduce infectivity. Clinically, it is mainly used for the treatment of influenza A and B in people aged 12 years and older. It features rapid onset, convenient administration, and good tolerability, and is currently a first-line targeted anti-influenza drug in clinical practice.In 2025, global production of Baloxavir Marboxil Tablets reached approximately 120 million tablets
As a new-generation anti-influenza drug, Baloxavir Marboxil Tablets (Xofluza) has rapidly become an important player in the global anti-influenza market relying on its core advantages of single oral dose, rapid onset and high compliance. Its unique cap-dependent endonuclease inhibition mechanism can block virus proliferation at the early stage of replication and significantly shorten the course of disease and infectious period. In the Chinese market, the drug has achieved rapid growth since its approval in 2021, and its accessibility has been significantly improved through medical insurance access, occupying a mainstream position in the high-end anti-influenza segment. With the successive launch of domestic generic drugs and innovative drugs, market competition has intensified, and the market will present a tripartite pattern of imported original drugs, domestic generic drugs and domestic innovative drugs in the future. Meanwhile, drug resistance risk and medical insurance cost control will become key factors affecting its long-term market development.
LP Information, Inc. (LPI) ' newest research report, the ?Masiroxavir Tablets Industry Forecast? looks at past sales and reviews total world Masiroxavir Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Masiroxavir Tablets sales for 2026 through 2032. With Masiroxavir Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Masiroxavir Tablets industry.
This Insight Report provides a comprehensive analysis of the global Masiroxavir Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Masiroxavir Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Masiroxavir Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Masiroxavir Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Masiroxavir Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Masiroxavir Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Masiroxavir Tablets market?
What factors are driving Masiroxavir Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Masiroxavir Tablets market opportunities vary by end market size?
How does Masiroxavir Tablets break out by Type, by Application?
Baloxavir Marboxil Tablets is a new, oral, single-dose anti-influenza virus drug belonging to cap-dependent endonuclease inhibitors. It exerts its effect by inhibiting influenza virus gene replication, which can rapidly eliminate the virus, shorten the course of disease, and reduce infectivity. Clinically, it is mainly used for the treatment of influenza A and B in people aged 12 years and older. It features rapid onset, convenient administration, and good tolerability, and is currently a first-line targeted anti-influenza drug in clinical practice.In 2025, global production of Baloxavir Marboxil Tablets reached approximately 120 million tablets
As a new-generation anti-influenza drug, Baloxavir Marboxil Tablets (Xofluza) has rapidly become an important player in the global anti-influenza market relying on its core advantages of single oral dose, rapid onset and high compliance. Its unique cap-dependent endonuclease inhibition mechanism can block virus proliferation at the early stage of replication and significantly shorten the course of disease and infectious period. In the Chinese market, the drug has achieved rapid growth since its approval in 2021, and its accessibility has been significantly improved through medical insurance access, occupying a mainstream position in the high-end anti-influenza segment. With the successive launch of domestic generic drugs and innovative drugs, market competition has intensified, and the market will present a tripartite pattern of imported original drugs, domestic generic drugs and domestic innovative drugs in the future. Meanwhile, drug resistance risk and medical insurance cost control will become key factors affecting its long-term market development.
LP Information, Inc. (LPI) ' newest research report, the ?Masiroxavir Tablets Industry Forecast? looks at past sales and reviews total world Masiroxavir Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Masiroxavir Tablets sales for 2026 through 2032. With Masiroxavir Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Masiroxavir Tablets industry.
This Insight Report provides a comprehensive analysis of the global Masiroxavir Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Masiroxavir Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Masiroxavir Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Masiroxavir Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Masiroxavir Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Masiroxavir Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 20 mg per tablet
- 40 mg per tablet
- Patients Aged 12 Years And Older With Influenza A
- Patients Aged 12 Years And Older With Influenza B
- Hospital
- Retail
- Online
- Innovator
- Generic
- Influenza A
- Influenza B
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Shionogi & Co.
- Roche
What is the 10-year outlook for the global Masiroxavir Tablets market?
What factors are driving Masiroxavir Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Masiroxavir Tablets market opportunities vary by end market size?
How does Masiroxavir Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Masiroxavir Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Masiroxavir Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Masiroxavir Tablets by Country/Region, 2021, 2025 & 2032
2.2 Masiroxavir Tablets Segment by Type
2.2.1 20 mg per tablet
2.2.2 40 mg per tablet
2.2.3 Masiroxavir Tablets Sales by Type
2.2.3.1 Global Masiroxavir Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Masiroxavir Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Masiroxavir Tablets Sale Price by Type (2021-2026)
2.3 Masiroxavir Tablets Segment by Target Population
2.3.1 Patients Aged 12 Years And Older With Influenza A
2.3.2 Patients Aged 12 Years And Older With Influenza B
2.3.3 Masiroxavir Tablets Sales by Target Population
2.3.3.1 Global Masiroxavir Tablets Sales Market Share by Target Population (2021-2026)
2.3.3.2 Global Masiroxavir Tablets Revenue and Market Share by Target Population (2021-2026)
2.3.3.3 Global Masiroxavir Tablets Sale Price by Target Population (2021-2026)
2.4 Masiroxavir Tablets Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Masiroxavir Tablets Sales by Sales Channels
2.4.4.1 Global Masiroxavir Tablets Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Masiroxavir Tablets Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Masiroxavir Tablets Sale Price by Sales Channels (2021-2026)
2.5 Masiroxavir Tablets Segment by Production Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Masiroxavir Tablets Sales by Production Technology
2.5.3.1 Global Masiroxavir Tablets Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Masiroxavir Tablets Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Masiroxavir Tablets Sale Price by Production Technology (2021-2026)
2.6 Masiroxavir Tablets Segment by Application
2.6.1 Influenza A
2.6.2 Influenza B
2.6.3 Others
2.6.4 Masiroxavir Tablets Sales by Application
2.6.4.1 Global Masiroxavir Tablets Sale Market Share by Application (2021-2026)
2.6.4.2 Global Masiroxavir Tablets Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Masiroxavir Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Masiroxavir Tablets Breakdown Data by Company
3.1.1 Global Masiroxavir Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Masiroxavir Tablets Sales Market Share by Company (2021-2026)
3.2 Global Masiroxavir Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Masiroxavir Tablets Revenue by Company (2021-2026)
3.2.2 Global Masiroxavir Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Masiroxavir Tablets Sale Price by Company
3.4 Key Manufacturers Masiroxavir Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Masiroxavir Tablets Product Location Distribution
3.4.2 Players Masiroxavir Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MASIROXAVIR TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Masiroxavir Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Masiroxavir Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Masiroxavir Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Masiroxavir Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Masiroxavir Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Masiroxavir Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Masiroxavir Tablets Sales Growth
4.4 APAC Masiroxavir Tablets Sales Growth
4.5 Europe Masiroxavir Tablets Sales Growth
4.6 Middle East & Africa Masiroxavir Tablets Sales Growth
5 AMERICAS
5.1 Americas Masiroxavir Tablets Sales by Country
5.1.1 Americas Masiroxavir Tablets Sales by Country (2021-2026)
5.1.2 Americas Masiroxavir Tablets Revenue by Country (2021-2026)
5.2 Americas Masiroxavir Tablets Sales by Type (2021-2026)
5.3 Americas Masiroxavir Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Masiroxavir Tablets Sales by Region
6.1.1 APAC Masiroxavir Tablets Sales by Region (2021-2026)
6.1.2 APAC Masiroxavir Tablets Revenue by Region (2021-2026)
6.2 APAC Masiroxavir Tablets Sales by Type (2021-2026)
6.3 APAC Masiroxavir Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Masiroxavir Tablets by Country
7.1.1 Europe Masiroxavir Tablets Sales by Country (2021-2026)
7.1.2 Europe Masiroxavir Tablets Revenue by Country (2021-2026)
7.2 Europe Masiroxavir Tablets Sales by Type (2021-2026)
7.3 Europe Masiroxavir Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Masiroxavir Tablets by Country
8.1.1 Middle East & Africa Masiroxavir Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Masiroxavir Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Masiroxavir Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Masiroxavir Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Masiroxavir Tablets
10.3 Manufacturing Process Analysis of Masiroxavir Tablets
10.4 Industry Chain Structure of Masiroxavir Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Masiroxavir Tablets Distributors
11.3 Masiroxavir Tablets Customer
12 WORLD FORECAST REVIEW FOR MASIROXAVIR TABLETS BY GEOGRAPHIC REGION
12.1 Global Masiroxavir Tablets Market Size Forecast by Region
12.1.1 Global Masiroxavir Tablets Forecast by Region (2027-2032)
12.1.2 Global Masiroxavir Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Masiroxavir Tablets Forecast by Type (2027-2032)
12.7 Global Masiroxavir Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Shionogi & Co.
13.1.1 Shionogi & Co. Company Information
13.1.2 Shionogi & Co. Masiroxavir Tablets Product Portfolios and Specifications
13.1.3 Shionogi & Co. Masiroxavir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Shionogi & Co. Main Business Overview
13.1.5 Shionogi & Co. Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Masiroxavir Tablets Product Portfolios and Specifications
13.2.3 Roche Masiroxavir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Masiroxavir Tablets Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Masiroxavir Tablets by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Masiroxavir Tablets by Country/Region, 2021, 2025 & 2032
2.2 Masiroxavir Tablets Segment by Type
2.2.1 20 mg per tablet
2.2.2 40 mg per tablet
2.2.3 Masiroxavir Tablets Sales by Type
2.2.3.1 Global Masiroxavir Tablets Sales Market Share by Type (2021-2026)
2.2.3.2 Global Masiroxavir Tablets Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Masiroxavir Tablets Sale Price by Type (2021-2026)
2.3 Masiroxavir Tablets Segment by Target Population
2.3.1 Patients Aged 12 Years And Older With Influenza A
2.3.2 Patients Aged 12 Years And Older With Influenza B
2.3.3 Masiroxavir Tablets Sales by Target Population
2.3.3.1 Global Masiroxavir Tablets Sales Market Share by Target Population (2021-2026)
2.3.3.2 Global Masiroxavir Tablets Revenue and Market Share by Target Population (2021-2026)
2.3.3.3 Global Masiroxavir Tablets Sale Price by Target Population (2021-2026)
2.4 Masiroxavir Tablets Segment by Sales Channels
2.4.1 Hospital
2.4.2 Retail
2.4.3 Online
2.4.4 Masiroxavir Tablets Sales by Sales Channels
2.4.4.1 Global Masiroxavir Tablets Sales Market Share by Sales Channels (2021-2026)
2.4.4.2 Global Masiroxavir Tablets Revenue and Market Share by Sales Channels (2021-2026)
2.4.4.3 Global Masiroxavir Tablets Sale Price by Sales Channels (2021-2026)
2.5 Masiroxavir Tablets Segment by Production Technology
2.5.1 Innovator
2.5.2 Generic
2.5.3 Masiroxavir Tablets Sales by Production Technology
2.5.3.1 Global Masiroxavir Tablets Sales Market Share by Production Technology (2021-2026)
2.5.3.2 Global Masiroxavir Tablets Revenue and Market Share by Production Technology (2021-2026)
2.5.3.3 Global Masiroxavir Tablets Sale Price by Production Technology (2021-2026)
2.6 Masiroxavir Tablets Segment by Application
2.6.1 Influenza A
2.6.2 Influenza B
2.6.3 Others
2.6.4 Masiroxavir Tablets Sales by Application
2.6.4.1 Global Masiroxavir Tablets Sale Market Share by Application (2021-2026)
2.6.4.2 Global Masiroxavir Tablets Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Masiroxavir Tablets Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Masiroxavir Tablets Breakdown Data by Company
3.1.1 Global Masiroxavir Tablets Annual Sales by Company (2021-2026)
3.1.2 Global Masiroxavir Tablets Sales Market Share by Company (2021-2026)
3.2 Global Masiroxavir Tablets Annual Revenue by Company (2021-2026)
3.2.1 Global Masiroxavir Tablets Revenue by Company (2021-2026)
3.2.2 Global Masiroxavir Tablets Revenue Market Share by Company (2021-2026)
3.3 Global Masiroxavir Tablets Sale Price by Company
3.4 Key Manufacturers Masiroxavir Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Masiroxavir Tablets Product Location Distribution
3.4.2 Players Masiroxavir Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR MASIROXAVIR TABLETS BY GEOGRAPHIC REGION
4.1 World Historic Masiroxavir Tablets Market Size by Geographic Region (2021-2026)
4.1.1 Global Masiroxavir Tablets Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Masiroxavir Tablets Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Masiroxavir Tablets Market Size by Country/Region (2021-2026)
4.2.1 Global Masiroxavir Tablets Annual Sales by Country/Region (2021-2026)
4.2.2 Global Masiroxavir Tablets Annual Revenue by Country/Region (2021-2026)
4.3 Americas Masiroxavir Tablets Sales Growth
4.4 APAC Masiroxavir Tablets Sales Growth
4.5 Europe Masiroxavir Tablets Sales Growth
4.6 Middle East & Africa Masiroxavir Tablets Sales Growth
5 AMERICAS
5.1 Americas Masiroxavir Tablets Sales by Country
5.1.1 Americas Masiroxavir Tablets Sales by Country (2021-2026)
5.1.2 Americas Masiroxavir Tablets Revenue by Country (2021-2026)
5.2 Americas Masiroxavir Tablets Sales by Type (2021-2026)
5.3 Americas Masiroxavir Tablets Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Masiroxavir Tablets Sales by Region
6.1.1 APAC Masiroxavir Tablets Sales by Region (2021-2026)
6.1.2 APAC Masiroxavir Tablets Revenue by Region (2021-2026)
6.2 APAC Masiroxavir Tablets Sales by Type (2021-2026)
6.3 APAC Masiroxavir Tablets Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Masiroxavir Tablets by Country
7.1.1 Europe Masiroxavir Tablets Sales by Country (2021-2026)
7.1.2 Europe Masiroxavir Tablets Revenue by Country (2021-2026)
7.2 Europe Masiroxavir Tablets Sales by Type (2021-2026)
7.3 Europe Masiroxavir Tablets Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Masiroxavir Tablets by Country
8.1.1 Middle East & Africa Masiroxavir Tablets Sales by Country (2021-2026)
8.1.2 Middle East & Africa Masiroxavir Tablets Revenue by Country (2021-2026)
8.2 Middle East & Africa Masiroxavir Tablets Sales by Type (2021-2026)
8.3 Middle East & Africa Masiroxavir Tablets Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Masiroxavir Tablets
10.3 Manufacturing Process Analysis of Masiroxavir Tablets
10.4 Industry Chain Structure of Masiroxavir Tablets
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Masiroxavir Tablets Distributors
11.3 Masiroxavir Tablets Customer
12 WORLD FORECAST REVIEW FOR MASIROXAVIR TABLETS BY GEOGRAPHIC REGION
12.1 Global Masiroxavir Tablets Market Size Forecast by Region
12.1.1 Global Masiroxavir Tablets Forecast by Region (2027-2032)
12.1.2 Global Masiroxavir Tablets Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Masiroxavir Tablets Forecast by Type (2027-2032)
12.7 Global Masiroxavir Tablets Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Shionogi & Co.
13.1.1 Shionogi & Co. Company Information
13.1.2 Shionogi & Co. Masiroxavir Tablets Product Portfolios and Specifications
13.1.3 Shionogi & Co. Masiroxavir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Shionogi & Co. Main Business Overview
13.1.5 Shionogi & Co. Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche Masiroxavir Tablets Product Portfolios and Specifications
13.2.3 Roche Masiroxavir Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. MasiroxavirTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. MasiroxavirTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 20 mg per tablet
Table 4. Major Players of 40 mg per tablet
Table 5. Global MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 6. Global MasiroxavirTablets Sales Market Share by Type (2021-2026)
Table 7. Global MasiroxavirTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global MasiroxavirTablets Revenue Market Share by Type (2021-2026)
Table 9. Global MasiroxavirTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Patients Aged 12 Years And Older With Influenza A
Table 11. Major Players of Patients Aged 12 Years And Older With Influenza B
Table 12. Global MasiroxavirTablets Sales by Target Population (2021-2026) & (Units)
Table 13. Global MasiroxavirTablets Sales Market Share by Target Population (2021-2026)
Table 14. Global MasiroxavirTablets Revenue by Target Population (2021-2026) & ($ million)
Table 15. Global MasiroxavirTablets Revenue Market Share by Target Population (2021-2026)
Table 16. Global MasiroxavirTablets Sale Price by Target Population (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global MasiroxavirTablets Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global MasiroxavirTablets Sales Market Share by Sales Channels (2021-2026)
Table 22. Global MasiroxavirTablets Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global MasiroxavirTablets Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global MasiroxavirTablets Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Major Players of Innovator
Table 26. Major Players of Generic
Table 27. Global MasiroxavirTablets Sales by Production Technology (2021-2026) & (Units)
Table 28. Global MasiroxavirTablets Sales Market Share by Production Technology (2021-2026)
Table 29. Global MasiroxavirTablets Revenue by Production Technology (2021-2026) & ($ million)
Table 30. Global MasiroxavirTablets Revenue Market Share by Production Technology (2021-2026)
Table 31. Global MasiroxavirTablets Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 32. Global MasiroxavirTablets Sale by Application (2021-2026) & (Units)
Table 33. Global MasiroxavirTablets Sale Market Share by Application (2021-2026)
Table 34. Global MasiroxavirTablets Revenue by Application (2021-2026) & ($ million)
Table 35. Global MasiroxavirTablets Revenue Market Share by Application (2021-2026)
Table 36. Global MasiroxavirTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global MasiroxavirTablets Sales by Company (2021-2026) & (Units)
Table 38. Global MasiroxavirTablets Sales Market Share by Company (2021-2026)
Table 39. Global MasiroxavirTablets Revenue by Company (2021-2026) & ($ millions)
Table 40. Global MasiroxavirTablets Revenue Market Share by Company (2021-2026)
Table 41. Global MasiroxavirTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers MasiroxavirTablets Producing Area Distribution and Sales Area
Table 43. Players MasiroxavirTablets Products Offered
Table 44. MasiroxavirTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global MasiroxavirTablets Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global MasiroxavirTablets Sales Market Share Geographic Region (2021-2026)
Table 49. Global MasiroxavirTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global MasiroxavirTablets Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global MasiroxavirTablets Sales by Country/Region (2021-2026) & (Units)
Table 52. Global MasiroxavirTablets Sales Market Share by Country/Region (2021-2026)
Table 53. Global MasiroxavirTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global MasiroxavirTablets Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas MasiroxavirTablets Sales by Country (2021-2026) & (Units)
Table 56. Americas MasiroxavirTablets Sales Market Share by Country (2021-2026)
Table 57. Americas MasiroxavirTablets Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 59. Americas MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 60. APAC MasiroxavirTablets Sales by Region (2021-2026) & (Units)
Table 61. APAC MasiroxavirTablets Sales Market Share by Region (2021-2026)
Table 62. APAC MasiroxavirTablets Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 64. APAC MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 65. Europe MasiroxavirTablets Sales by Country (2021-2026) & (Units)
Table 66. Europe MasiroxavirTablets Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 68. Europe MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa MasiroxavirTablets Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa MasiroxavirTablets Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of MasiroxavirTablets
Table 74. Key Market Challenges & Risks of MasiroxavirTablets
Table 75. Key Industry Trends of MasiroxavirTablets
Table 76. MasiroxavirTablets Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. MasiroxavirTablets Distributors List
Table 79. MasiroxavirTablets Customer List
Table 80. Global MasiroxavirTablets Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global MasiroxavirTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas MasiroxavirTablets Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas MasiroxavirTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC MasiroxavirTablets Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC MasiroxavirTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe MasiroxavirTablets Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe MasiroxavirTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa MasiroxavirTablets Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa MasiroxavirTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global MasiroxavirTablets Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global MasiroxavirTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global MasiroxavirTablets Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global MasiroxavirTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Shionogi & Co. Basic Information, MasiroxavirTablets Manufacturing Base, Sales Area and Its Competitors
Table 95. Shionogi & Co. MasiroxavirTablets Product Portfolios and Specifications
Table 96. Shionogi & Co. MasiroxavirTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Shionogi & Co. Main Business
Table 98. Shionogi & Co. Latest Developments
Table 99. Roche Basic Information, MasiroxavirTablets Manufacturing Base, Sales Area and Its Competitors
Table 100. Roche MasiroxavirTablets Product Portfolios and Specifications
Table 101. Roche MasiroxavirTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Roche Main Business
Table 103. Roche Latest Developments
Table 1. MasiroxavirTablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. MasiroxavirTablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 20 mg per tablet
Table 4. Major Players of 40 mg per tablet
Table 5. Global MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 6. Global MasiroxavirTablets Sales Market Share by Type (2021-2026)
Table 7. Global MasiroxavirTablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global MasiroxavirTablets Revenue Market Share by Type (2021-2026)
Table 9. Global MasiroxavirTablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Patients Aged 12 Years And Older With Influenza A
Table 11. Major Players of Patients Aged 12 Years And Older With Influenza B
Table 12. Global MasiroxavirTablets Sales by Target Population (2021-2026) & (Units)
Table 13. Global MasiroxavirTablets Sales Market Share by Target Population (2021-2026)
Table 14. Global MasiroxavirTablets Revenue by Target Population (2021-2026) & ($ million)
Table 15. Global MasiroxavirTablets Revenue Market Share by Target Population (2021-2026)
Table 16. Global MasiroxavirTablets Sale Price by Target Population (2021-2026) & (US$/Unit)
Table 17. Major Players of Hospital
Table 18. Major Players of Retail
Table 19. Major Players of Online
Table 20. Global MasiroxavirTablets Sales by Sales Channels (2021-2026) & (Units)
Table 21. Global MasiroxavirTablets Sales Market Share by Sales Channels (2021-2026)
Table 22. Global MasiroxavirTablets Revenue by Sales Channels (2021-2026) & ($ million)
Table 23. Global MasiroxavirTablets Revenue Market Share by Sales Channels (2021-2026)
Table 24. Global MasiroxavirTablets Sale Price by Sales Channels (2021-2026) & (US$/Unit)
Table 25. Major Players of Innovator
Table 26. Major Players of Generic
Table 27. Global MasiroxavirTablets Sales by Production Technology (2021-2026) & (Units)
Table 28. Global MasiroxavirTablets Sales Market Share by Production Technology (2021-2026)
Table 29. Global MasiroxavirTablets Revenue by Production Technology (2021-2026) & ($ million)
Table 30. Global MasiroxavirTablets Revenue Market Share by Production Technology (2021-2026)
Table 31. Global MasiroxavirTablets Sale Price by Production Technology (2021-2026) & (US$/Unit)
Table 32. Global MasiroxavirTablets Sale by Application (2021-2026) & (Units)
Table 33. Global MasiroxavirTablets Sale Market Share by Application (2021-2026)
Table 34. Global MasiroxavirTablets Revenue by Application (2021-2026) & ($ million)
Table 35. Global MasiroxavirTablets Revenue Market Share by Application (2021-2026)
Table 36. Global MasiroxavirTablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 37. Global MasiroxavirTablets Sales by Company (2021-2026) & (Units)
Table 38. Global MasiroxavirTablets Sales Market Share by Company (2021-2026)
Table 39. Global MasiroxavirTablets Revenue by Company (2021-2026) & ($ millions)
Table 40. Global MasiroxavirTablets Revenue Market Share by Company (2021-2026)
Table 41. Global MasiroxavirTablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 42. Key Manufacturers MasiroxavirTablets Producing Area Distribution and Sales Area
Table 43. Players MasiroxavirTablets Products Offered
Table 44. MasiroxavirTablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 45. New Products and Potential Entrants
Table 46. Market M&A Activity & Strategy
Table 47. Global MasiroxavirTablets Sales by Geographic Region (2021-2026) & (Units)
Table 48. Global MasiroxavirTablets Sales Market Share Geographic Region (2021-2026)
Table 49. Global MasiroxavirTablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 50. Global MasiroxavirTablets Revenue Market Share by Geographic Region (2021-2026)
Table 51. Global MasiroxavirTablets Sales by Country/Region (2021-2026) & (Units)
Table 52. Global MasiroxavirTablets Sales Market Share by Country/Region (2021-2026)
Table 53. Global MasiroxavirTablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 54. Global MasiroxavirTablets Revenue Market Share by Country/Region (2021-2026)
Table 55. Americas MasiroxavirTablets Sales by Country (2021-2026) & (Units)
Table 56. Americas MasiroxavirTablets Sales Market Share by Country (2021-2026)
Table 57. Americas MasiroxavirTablets Revenue by Country (2021-2026) & ($ millions)
Table 58. Americas MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 59. Americas MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 60. APAC MasiroxavirTablets Sales by Region (2021-2026) & (Units)
Table 61. APAC MasiroxavirTablets Sales Market Share by Region (2021-2026)
Table 62. APAC MasiroxavirTablets Revenue by Region (2021-2026) & ($ millions)
Table 63. APAC MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 64. APAC MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 65. Europe MasiroxavirTablets Sales by Country (2021-2026) & (Units)
Table 66. Europe MasiroxavirTablets Revenue by Country (2021-2026) & ($ millions)
Table 67. Europe MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 68. Europe MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 69. Middle East & Africa MasiroxavirTablets Sales by Country (2021-2026) & (Units)
Table 70. Middle East & Africa MasiroxavirTablets Revenue Market Share by Country (2021-2026)
Table 71. Middle East & Africa MasiroxavirTablets Sales by Type (2021-2026) & (Units)
Table 72. Middle East & Africa MasiroxavirTablets Sales by Application (2021-2026) & (Units)
Table 73. Key Market Drivers & Growth Opportunities of MasiroxavirTablets
Table 74. Key Market Challenges & Risks of MasiroxavirTablets
Table 75. Key Industry Trends of MasiroxavirTablets
Table 76. MasiroxavirTablets Raw Material
Table 77. Key Suppliers of Raw Materials
Table 78. MasiroxavirTablets Distributors List
Table 79. MasiroxavirTablets Customer List
Table 80. Global MasiroxavirTablets Sales Forecast by Region (2027-2032) & (Units)
Table 81. Global MasiroxavirTablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 82. Americas MasiroxavirTablets Sales Forecast by Country (2027-2032) & (Units)
Table 83. Americas MasiroxavirTablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 84. APAC MasiroxavirTablets Sales Forecast by Region (2027-2032) & (Units)
Table 85. APAC MasiroxavirTablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 86. Europe MasiroxavirTablets Sales Forecast by Country (2027-2032) & (Units)
Table 87. Europe MasiroxavirTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Middle East & Africa MasiroxavirTablets Sales Forecast by Country (2027-2032) & (Units)
Table 89. Middle East & Africa MasiroxavirTablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 90. Global MasiroxavirTablets Sales Forecast by Type (2027-2032) & (Units)
Table 91. Global MasiroxavirTablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 92. Global MasiroxavirTablets Sales Forecast by Application (2027-2032) & (Units)
Table 93. Global MasiroxavirTablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 94. Shionogi & Co. Basic Information, MasiroxavirTablets Manufacturing Base, Sales Area and Its Competitors
Table 95. Shionogi & Co. MasiroxavirTablets Product Portfolios and Specifications
Table 96. Shionogi & Co. MasiroxavirTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Shionogi & Co. Main Business
Table 98. Shionogi & Co. Latest Developments
Table 99. Roche Basic Information, MasiroxavirTablets Manufacturing Base, Sales Area and Its Competitors
Table 100. Roche MasiroxavirTablets Product Portfolios and Specifications
Table 101. Roche MasiroxavirTablets Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Roche Main Business
Table 103. Roche Latest Developments
LIST OF FIGURES
Figure 1. Picture of MasiroxavirTablets
Figure 2. MasiroxavirTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MasiroxavirTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global MasiroxavirTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. MasiroxavirTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. MasiroxavirTablets Sales Market Share by Country/Region (2025)
Figure 10. MasiroxavirTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 20 mg per tablet
Figure 12. Product Picture of 40 mg per tablet
Figure 13. Global MasiroxavirTablets Sales Market Share by Type in 2026
Figure 14. Global MasiroxavirTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Patients Aged 12 Years And Older With Influenza A
Figure 16. Product Picture of Patients Aged 12 Years And Older With Influenza B
Figure 17. Global MasiroxavirTablets Sales Market Share by Target Population in 2026
Figure 18. Global MasiroxavirTablets Revenue Market Share by Target Population (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global MasiroxavirTablets Sales Market Share by Sales Channels in 2026
Figure 23. Global MasiroxavirTablets Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Product Picture of Innovator
Figure 25. Product Picture of Generic
Figure 26. Global MasiroxavirTablets Sales Market Share by Production Technology in 2026
Figure 27. Global MasiroxavirTablets Revenue Market Share by Production Technology (2021-2026)
Figure 28. MasiroxavirTablets Consumed in Influenza A
Figure 29. Global MasiroxavirTablets Market: Influenza A (2021-2026) & (Units)
Figure 30. MasiroxavirTablets Consumed in Influenza B
Figure 31. Global MasiroxavirTablets Market: Influenza B (2021-2026) & (Units)
Figure 32. MasiroxavirTablets Consumed in Others
Figure 33. Global MasiroxavirTablets Market: Others (2021-2026) & (Units)
Figure 34. Global MasiroxavirTablets Sale Market Share by Application (2025)
Figure 35. Global MasiroxavirTablets Revenue Market Share by Application in 2025
Figure 36. MasiroxavirTablets Sales by Company in 2025 (Units)
Figure 37. Global MasiroxavirTablets Sales Market Share by Company in 2025
Figure 38. MasiroxavirTablets Revenue by Company in 2025 ($ millions)
Figure 39. Global MasiroxavirTablets Revenue Market Share by Company in 2025
Figure 40. Global MasiroxavirTablets Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global MasiroxavirTablets Revenue Market Share by Geographic Region in 2025
Figure 42. Americas MasiroxavirTablets Sales 2021-2026 (Units)
Figure 43. Americas MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 44. APAC MasiroxavirTablets Sales 2021-2026 (Units)
Figure 45. APAC MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 46. Europe MasiroxavirTablets Sales 2021-2026 (Units)
Figure 47. Europe MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa MasiroxavirTablets Sales 2021-2026 (Units)
Figure 49. Middle East & Africa MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 50. Americas MasiroxavirTablets Sales Market Share by Country in 2025
Figure 51. Americas MasiroxavirTablets Revenue Market Share by Country (2021-2026)
Figure 52. Americas MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 53. Americas MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 54. United States MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC MasiroxavirTablets Sales Market Share by Region in 2025
Figure 59. APAC MasiroxavirTablets Revenue Market Share by Region (2021-2026)
Figure 60. APAC MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 61. APAC MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 62. China MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 66. India MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe MasiroxavirTablets Sales Market Share by Country in 2025
Figure 70. Europe MasiroxavirTablets Revenue Market Share by Country (2021-2026)
Figure 71. Europe MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 72. Europe MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 73. Germany MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. France MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 75. UK MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa MasiroxavirTablets Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 81. Egypt MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of MasiroxavirTablets in 2026
Figure 87. Manufacturing Process Analysis of MasiroxavirTablets
Figure 88. Industry Chain Structure of MasiroxavirTablets
Figure 89. Channels of Distribution
Figure 90. Global MasiroxavirTablets Sales Market Forecast by Region (2027-2032)
Figure 91. Global MasiroxavirTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global MasiroxavirTablets Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global MasiroxavirTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global MasiroxavirTablets Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global MasiroxavirTablets Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of MasiroxavirTablets
Figure 2. MasiroxavirTablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MasiroxavirTablets Sales Growth Rate 2021-2032 (Units)
Figure 7. Global MasiroxavirTablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. MasiroxavirTablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. MasiroxavirTablets Sales Market Share by Country/Region (2025)
Figure 10. MasiroxavirTablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 20 mg per tablet
Figure 12. Product Picture of 40 mg per tablet
Figure 13. Global MasiroxavirTablets Sales Market Share by Type in 2026
Figure 14. Global MasiroxavirTablets Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Patients Aged 12 Years And Older With Influenza A
Figure 16. Product Picture of Patients Aged 12 Years And Older With Influenza B
Figure 17. Global MasiroxavirTablets Sales Market Share by Target Population in 2026
Figure 18. Global MasiroxavirTablets Revenue Market Share by Target Population (2021-2026)
Figure 19. Product Picture of Hospital
Figure 20. Product Picture of Retail
Figure 21. Product Picture of Online
Figure 22. Global MasiroxavirTablets Sales Market Share by Sales Channels in 2026
Figure 23. Global MasiroxavirTablets Revenue Market Share by Sales Channels (2021-2026)
Figure 24. Product Picture of Innovator
Figure 25. Product Picture of Generic
Figure 26. Global MasiroxavirTablets Sales Market Share by Production Technology in 2026
Figure 27. Global MasiroxavirTablets Revenue Market Share by Production Technology (2021-2026)
Figure 28. MasiroxavirTablets Consumed in Influenza A
Figure 29. Global MasiroxavirTablets Market: Influenza A (2021-2026) & (Units)
Figure 30. MasiroxavirTablets Consumed in Influenza B
Figure 31. Global MasiroxavirTablets Market: Influenza B (2021-2026) & (Units)
Figure 32. MasiroxavirTablets Consumed in Others
Figure 33. Global MasiroxavirTablets Market: Others (2021-2026) & (Units)
Figure 34. Global MasiroxavirTablets Sale Market Share by Application (2025)
Figure 35. Global MasiroxavirTablets Revenue Market Share by Application in 2025
Figure 36. MasiroxavirTablets Sales by Company in 2025 (Units)
Figure 37. Global MasiroxavirTablets Sales Market Share by Company in 2025
Figure 38. MasiroxavirTablets Revenue by Company in 2025 ($ millions)
Figure 39. Global MasiroxavirTablets Revenue Market Share by Company in 2025
Figure 40. Global MasiroxavirTablets Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global MasiroxavirTablets Revenue Market Share by Geographic Region in 2025
Figure 42. Americas MasiroxavirTablets Sales 2021-2026 (Units)
Figure 43. Americas MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 44. APAC MasiroxavirTablets Sales 2021-2026 (Units)
Figure 45. APAC MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 46. Europe MasiroxavirTablets Sales 2021-2026 (Units)
Figure 47. Europe MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa MasiroxavirTablets Sales 2021-2026 (Units)
Figure 49. Middle East & Africa MasiroxavirTablets Revenue 2021-2026 ($ millions)
Figure 50. Americas MasiroxavirTablets Sales Market Share by Country in 2025
Figure 51. Americas MasiroxavirTablets Revenue Market Share by Country (2021-2026)
Figure 52. Americas MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 53. Americas MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 54. United States MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC MasiroxavirTablets Sales Market Share by Region in 2025
Figure 59. APAC MasiroxavirTablets Revenue Market Share by Region (2021-2026)
Figure 60. APAC MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 61. APAC MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 62. China MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 66. India MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe MasiroxavirTablets Sales Market Share by Country in 2025
Figure 70. Europe MasiroxavirTablets Revenue Market Share by Country (2021-2026)
Figure 71. Europe MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 72. Europe MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 73. Germany MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 74. France MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 75. UK MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa MasiroxavirTablets Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa MasiroxavirTablets Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa MasiroxavirTablets Sales Market Share by Application (2021-2026)
Figure 81. Egypt MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries MasiroxavirTablets Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of MasiroxavirTablets in 2026
Figure 87. Manufacturing Process Analysis of MasiroxavirTablets
Figure 88. Industry Chain Structure of MasiroxavirTablets
Figure 89. Channels of Distribution
Figure 90. Global MasiroxavirTablets Sales Market Forecast by Region (2027-2032)
Figure 91. Global MasiroxavirTablets Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global MasiroxavirTablets Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global MasiroxavirTablets Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global MasiroxavirTablets Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global MasiroxavirTablets Revenue Market Share Forecast by Application (2027-2032)
